Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds

Life Sci. 1983:33 Suppl 1:477-80. doi: 10.1016/0024-3205(83)90545-3.

Abstract

The peripheral selectivity of the newer quaternary narcotic antagonist levallorphan methyl iodide (SR 58002) was found superior in mice to those of the previously available compounds N-allyl levallorphan (CM 32191), N-methyl nalorphine (MNph) and N-methyl naloxone (MNx). SR 58002 and MNph were the most potent (ID50, mg/kg s.c., 3.6 and 3.7) in preventing constipation by s.c. morphine (charcoal meal). Antinociception (hot-plate) of s.c. morphine was completely prevented by MNx, MNph and CM 32191 (ID50, mg/kg s.c., 1.6, 8.6 and 15.2) but only partially antagonized by 30 mg/kg s.c. SR 58002. Constipation elicited centrally by intracerebroventricular (i.c.v.) morphine was prevented by either s.c. MNx or MNph but not by SR 58002 or CM 32191, up to 60 mg/kg.

MeSH terms

  • Animals
  • Constipation / physiopathology
  • Female
  • Gastrointestinal Motility / drug effects*
  • Levallorphan / analogs & derivatives*
  • Levallorphan / pharmacology
  • Mice
  • Morphine / pharmacology
  • Naloxone / pharmacology
  • Structure-Activity Relationship

Substances

  • Levallorphan
  • Naloxone
  • N-methyllevallorphan
  • Morphine